New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease

@article{Goetz2010NewDI,
  title={New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease},
  author={Christopher G Goetz},
  journal={Movement Disorders},
  year={2010},
  volume={25}
}
  • C. Goetz
  • Published 2010
  • Psychology, Medicine
  • Movement Disorders
Increasing research efforts are focused on nonmotor aspects of Parkinson's disease (PD). Depression, anxiety, compulsivity (dopamine dysregulation symptoms), and hallucinations/psychosis are among these disorders, and all complicate the management of PD with negative influences on quality of life. There is a strong overlap between depression and apathy and likewise, depression and anxiety can coexist and require careful pharmacologic management. Dopamine dysregulation syndrome is linked to… 
Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review.
TLDR
Results of individual studies varied significantly; however, the randomized controlled trials showed encouraging results and support the need for further investigation of the utility of CBT for depressed and anxious patients with PD.
The psychosis spectrum in Parkinson disease
TLDR
This work discusses recent developments, including recognition of an increase in the prevalence of psychosis with disease duration, addition of new visual symptoms to the psychosis continuum, and identification of frontal executive, visual perceptual and memory dysfunction at different disease stages.
Psychosis and Parkinson’s Disease
TLDR
Effective and well-studied treatments that improve Parkinson’s disease psychosis without worsening motor function are still needed.
Diagnostic Overshadowing of Anxiety in Parkinson Disease: Psychosocial Factors and a Cognitive-Behavioral Model
TLDR
A prominent finding was that individuals with motor fluctuation appeared to be more vulnerable to anxiety, and a cognitive-behavioral model of anxiety in PD is proposed and illustrated with a clinical example.
[Sleep disturbances in patients with Parkinson disease].
TLDR
The favorable responses to dopaminergic medications in treating both RLS and PD suggest shared pathophysiologies between the two diseases; however, neuroimaging studies of dopamine systems remain inconclusive.
Management of anxiety and motor symptoms in Parkinson’s disease
TLDR
This review considers the cyclic interaction between anxiety and motor symptoms in PD, each exacerbating the other when they coexist.
Motion and emotion: anxiety–axial connections in Parkinson’s disease
TLDR
Whether PD patients suffering from axial symptoms have higher levels of anxiety than others is determined and other factors associated with anxiety–axial connections are identified to provide complex management options of these serious symptoms.
Anxiety and depression in patients with Parkinson's disease.
TLDR
Findings indicate that recognizing anxiety and depression in patients with PD is important, since both conditions are commonly observed in Patients with PD and are similarly associated with the QOL, independent of motor severity.
Risk factors for visual hallucinations in patients with Parkinson’s disease
TLDR
The data show that the presence of vivid dreams is associated with VHs in PD and reaffirm thatVHs are linked to cognitive impairment, and Investigating vivid dreams may help the identification of VHS in PD.
...
...

References

SHOWING 1-10 OF 83 REFERENCES
Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group
TLDR
The proposed diagnostic criteria are provisional and intended to be defined further and validated but provide a common starting point for clinical research in PD‐associated depression.
Psychiatric comorbidity in a population of Parkinson's disease patients
TLDR
The findings might suggest the existence of a wide spectrum of psychiatric disorders in PD ranging from pure depressive disorders, comorbid depressive and anxiety disorders, and pure anxiety Disorders, presumably linked to the same neurobiological substrate.
Medication-related impulse control and repetitive behaviors in Parkinson's disease
TLDR
Clinicians should warn patients prior to initiating dopamine agonists and enquire about these behaviors during follow up, which can affect up to 14% of Parkinson's disease patients on dopamine agonist medications.
Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
  • B. Ravina, K. Marder, C. Goetz
  • Psychology, Medicine
    Movement disorders : official journal of the Movement Disorder Society
  • 2007
TLDR
It is suggested that PDPsy may result from progression of the disease process underlying PD, rather than a comorbid psychiatric disorder or drug intoxication, and are a potential indication for therapy development.
Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.
TLDR
Findings indicate that, when minor hallucinations are included, the total prevalence of hallucinations in Parkinson's disease is much higher than previously reported, and a simple side-effect of dopaminergic treatment is not sufficient to explain the occurrence of all visual hallucinations.
Major and minor depression in Parkinson's disease: a neuropsychological investigation
TLDR
The results indicate that major depression in PD is associated with a qualitatively specific neuropsychological profile that may be related to an alteration of prefrontal and limbic cortical areas, and suggests that in these patients MiD and MD may represent a gradual continuum associated with increasing cognitive deficits.
Depression rating scales in Parkinson's disease: Critique and recommendations
TLDR
A systematic literature review was conducted to explore the use of depression scales in PD and determine which scales should be selected, and found that the complex and time‐consuming task of developing a new scale to measure depression specifically for patients with PD is currently not warranted.
Prospective study of hallucinations and delusions in Parkinson's disease.
TLDR
The results suggest that several underlying characteristics of patients with Parkinson's disease (disease severity, dementia, depression, worse visual acuity) may be more important determinants of which patients experience hallucinations.
...
...